Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Interventional
Official Title: A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN0
Brief Summary: The purpose of this study is to evaluate the long-term safety and tolerability of multiple intravenous (IV) infusions of BMS-986168 in patients with Progressive Supranuclear Palsy (PSP). The study will also assess the pharmacodynamic (PD) effects of BMS-986168 on cerebrospinal fluid (CSF) extracellular tau (eTau), pharmacokinetics (PK), and immunogenicity of BMS-986168 in patients with Progressive Supranuclear Palsy.